,83,104, 105, 106,108 Of interest, a study on 23 melanoma patients showed that responders to anti-PD-1 monotherapy displayed conjointly an increased clonality and richness (and by extension diversity) in their tumor upon treatment.108. This evidence concerns the gene PDCD1 and neoplasm.